XML 438 R101.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity (Share-based Payments to Employees, Non-marketable Options) (Details) - Non-marketable Options [Member]
shares in Thousands
 12 Months Ended
Dec. 31, 2024
shares
Officers and senior employees [Member] | June 30, 2016 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 3,035
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date June 30, 2023
Officers and senior employees [Member] | February 14, 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expiration date February 14, 2024
Officers and senior employees [Member] | June 20, 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 6,868
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date June 20, 2024
Officers and senior employees [Member] | March 6 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 5,554
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date March 6, 2025
Officers and senior employees [Member] | February 14 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Officers and senior employees [Member] | April 4, 2024 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Former chairman of BOD [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Former chairman of BOD [Member] | September 5, 2016 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 186
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date June 30, 2023
Former chairman of BOD [Member] | August 2, 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 165
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date June 20, 2024
Former chairman of BOD [Member] | August 20, 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 403
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date August 20, 2025
Former chairman of BOD [Member] | February 14 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Former Chief Executive Officer [Member] | February 14, 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Former Chief Executive Officer [Member] | May 14, 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Former Ceo [Member] | February 14, 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 114
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Former Ceo [Member] | May 14, 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 385
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Expiration date May 14, 2025
Former Ceo [Member] | June 27, 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 3,512
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 2 equal tranches: (1) half at the end of 24 months after the grant date. (2) half at the end of 36 months after the grant date.
Expiration date 5 years after the grant date
Former Ceo [Member] | March 30, 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 1,941
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date 5 years after the grant date
Officers and senior manager [Member] | April 15, 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 13,242
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 2 equal tranches: (1) half at the end of 24 months after the grant date. (2) half at the end of 36 months after the grant date.
Expiration date 5 years after the grant date
Officers and senior manager [Member] | April 4, 2024 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 12,333
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date 5 years after the grant date
Chairman BOD [Member] | May 29 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 2,169 [1]
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 2 equal tranches: (1) half at the end of 24 months after the grant date. (2) half at the end of 36 months after the grant date.
Expiration date 5 years after the grant date
Chairman BOD [Member] | March 30, 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 1,055
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date 5 years after the grant date
Senior Employees [Member] | June 30, 2021 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 647
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 2 equal tranches: (1) half at the end of 24 months after the grant date. (2) half at the end of 36 months after the grant date.
Expiration date 5 years after the grant date
Senior Employees [Member] | February 8, 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 9,294
Issuance's details An issuance of non-marketable and non-transferrable options, for no consideration, under the 2014 Equity Compensation Plan, as amended in June 2016 (hereinafter – the amended 2014 Equity Compensation Plan).
Instrument terms Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company.
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date 5 years after the grant date
Senior Managers [Member] | February 14 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Number Of Instruments 461
Vesting conditions 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Expiration date 5 years after the grant date
[1] The options were issued upon Mr. Doppelt's entry into office on July 1, 2019.